Effect of chemotherapy on circulating gastrointestinal hormone levels in ovarian cancer patients: Relationship to nausea and vomiting

Scandinavian Journal of Gastroenterology

Volumn 40, Issue 6, 2005, Pages 654-661

  Hursti, Timo J ^a   Börjeson, Sussanne ^b   Hellström, Per M ^c   Åvall Lundqvist, Elisabeth ^c   Stock, Solveig ^c   Steineck, Gunnar ^c   Peterson, Curt ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cancer; Chemotherapy; Gastrointestinal hormones; Nausea; Vomiting

Indexed keywords

BETAMETHASONE; CHOLECYSTOKININ; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; GASTRIN; GASTROINTESTINAL HORMONE; GLUCOSE; GRANISETRON; HYDROCORTISONE; INSULIN; MOTILIN; ONDANSETRON; OXYTOCIN; PROSTAGLANDIN F2 ALPHA; SEROTONIN 3 ANTAGONIST; TROPISETRON;

ADULT; AGED; ARTICLE; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTRIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; INSULIN BLOOD LEVEL; NAUSEA AND VOMITING; OVARY CANCER; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CISPLATIN; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HORMONES; HUMANS; MIDDLE AGED; NAUSEA; OVARIAN NEOPLASMS; PILOT PROJECTS; PROBABILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TREATMENT OUTCOME; VOMITING;

EID: 20444466080     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/0036552051001163     Document Type: Article

References (23)

1. Cubbedu LX, Hoffman IS, Jobson VN. Cisplatin chemotherapy and the role of serotonin in cisplatin-induced nausea and vomiting. N Engl J Med 1990;307:250-1.
2. Hesketh PJ, Harvey WH, Harker WG, Beck TM, Ryan T, Bricker LJ, et al. A randomised, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis. J Clin Oncol 1994;12:596-600.
3. Hursti TJ, Åvall-Lundqvist E, Börjeson S, Fredrikson M, Fürst CJ, Steineck G, et al. The impact of tumour burden on chemotherapy induced nausea and vomiting. Br J Cancer 1996;70:1114-9.
4. Navari RM, Madajewics S, Anderson N, Tchekmedyian NS, Whaley W, Garewal H, et al. Oral ondansetron for the control of cisplatin-induced delayed emesis: a large, multicenter, double-blind, randomised comparative trial of ondansetron versus placebo. J Clin Oncol 1995;13:2408-16.
5. Kris MG, Gralla RJ, Clark RA, Tyson LB, O'Connell JP, Wertheim MS, et al. Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin. J Clin Oncol 1985;3:3179-84.
6. Andrews PLR, Davis CJ. The mechanism of emesis induced by anti-cancer therapies. In: Andrews PLR, Sanger GJ, editors. Emesis in anti-cancer therapy, mechanisms and treatment. London: Chapman & Hall; 1993. pp 113-61.
7. Pecorelli S. 25th Annual Report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2003;83 Suppl 1.
8. Näslund E, Melin M, Grybäck P, Hagg A, Hellstrom PM, Jacobsson H, et al. Reduced food intake after jejunoileal bypass: a possible association with prolonged gastric emptying and altered gut hormones. Am J Clin Nutr 1997;65:26-32.
9. Medhus AW, Sandstad O, Näslund E, Hellstrom PM, Husebye E. The influence of migrating motor complex on postprandial endocrine response. Scand J Gastroenterol 1999;34:1012-8.
10. Näslund E, Bogefors J, Grybäck P, Bjellerup P, Jacobsson H, Holst JJ, et al. GLP-1 inhibits gastric emptying of water but does not influence plasma vasopressin, sodium, or osmolality. Scand J Gastroenterol 2001;36:156-62.
11. Uvnäs-Moberg K, Sjögren C, Westlin L, Andersson PO, Stock S. Plasma levels of gastrin, somatostatin, VIP, insulin and oxytocin during menstrual cycle in women (with and without oral contraceptives). Acta Obstet Gynecol Scand 1989;68:165-9.
12. Larsen PR, Kronenberg HM, Melmed S, Polonsky KS. Williams textbook of endocrinology. Philadelphia, Pa.: W.B. Saunders; 2003.
13. Blanc VF, Ruest P, Brisson G, Jacob JL. Serum gastrin and blood glucose levels during halothane-nitrous oxide anaesthesia and strabismus surgery in children. Can J Anaesth 1991;38:43-8.
14. Eva Oddby-Muhrbeck. Postoperative nausea and vomiting in women. An unglamorous aspect of anaesthesia. Dissertation, Division of Anaesthesia and Intensive Care, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden, 2002.
15. Uvnäs-Wallensten K, Goiny M. Effect of apomorphine on peripheral venous gastrin and insulin levels in conscious dogs. Acta Physiol Scand 1981;112:155-60.
16. Goiny M, Uvnäs-Moberg K. Effects of dopamine receptor antagonists on gastrin and vomiting responses to apomorphine. Naunyn Schmiedebergs Arch Pharmacol 1987;336: 16-9.
17. Kris MG, Pisters KMW, Hinkley L. Delayed emesis following anticancer chemotherapy. Supp Care Cancer 1994;2: 297-300.
18. Jenner P, Marsden CD. The substituted benzamides: a novel class of dopamine antagonists. Life Sci 1979;25:479-85.
19. Itoh Z, Honda R, Hitwatashi K, Takeuchi S, Aizawa I, Takayanagi AR, et al. Motilin-induced mechanical activity in the canine alimentary tract. Scand J Gastroenterol 1976;11 Suppl 39:93-110.
20. Talley NJ, Phillips SF, Haddad A, Miller LJ, Twomey C, Zinsmeister AR, et al. GR 38032F (ondansetron), a selective 5-HT3 receptor antagonist, slows colonic transit in healthy man. Dig Dis Sci 1990;35:477-80.
21. Dawson J, Bryant MG, Cox AG, Christofides ND, Bloom SR, Peters TJ. Subcellular localization of serotonin and motilin in the human jejunum. Clin Sci (Lond) 1980;59: 505-8.
22. Plaza MA, Arruebo MP, Murillo MD. Involvment of somatostatin, bombesin and serotonin in the origin of the migrating myoelectric complex in sheep. Life Sci 1996;58: 2155-65.
23. Peterson C, Hursti TJ, Börjeson S, Avall-Lundqvist E, Fredrikson M, Furst CJ, et al. Single high-dose dexamethasone improves the effect of ondansetron on acute chemoptherapy-induced emesis but impairs the control of delayed symptoms. Supp Care Cancer 1996;4:440-6.